Introduction: Tuberculosis remains the leading causes of death worldwide with frequencies of mutations in rifampicin and isoniazid resistant Mycobacterium tuberculosis isolates varying according to geographical location. There is limited information in Zimbabwe on specific antibiotic resistance gene mutation patterns in MTB and hence, increased rate of discordant results and mortality due to inappropriate antibiotic prescriptions. The rpoB and katG genes molecular markers are used for detecting rifampicin and isoniazid resistance respectively. Some mutations within these gene sequences are associated with drug resistance as they directly alter gene function. The objectives of this research was to determine the drug resistance profiles in M. tuberculosis isolates that are phenotypically resistant but not detected by the GeneXpert and MTBDRplus kit and also to detect mutations in the rpoB and katG genes which are not detected by the Hain Genotype MTBDRplus kit and GeneXpert diagnosis. Methods: PCR was used for the amplification of the rpoB and katG genes from MTB isolates collected from human clinical samples between 2008 and 2015. The genes were sequenced and compared to the wild type MTB H37Rv rpoB (accession number L27989) and kat G genes (KP46920), respectively. Sequence analysis results were compared to genotyping results obtained from molecular assays and culture results of all isolates. Results: The most frequent mutation responsible for rifampicin resistance was (25/92) S531L that was detected by using all molecular assays. Some inconsistencies were observed between phenotypic and genotypic assay results for both katG and rpoB genes in 30 strains. For these, eight codons; G507S, T508A, L511V, del513-526, P520P, L524L, R528H, R529Q and S531F were novel mutations. In addition, the I572P/F, E562Q, P564S, and Q490Y mutations were identified as novel mutations outside the rifampicin resistance determining region. In katG gene, amino acid changes to threonine, asparagine and isoleucine exhibited high degrees of polymorphism such as V473N, D311N, and L427I. The R463L (20/92) amino acid substitution was most common but was not associated with isoniazid resistance. Conclusion: These finding indicate that molecular assay kit diagnosis that is based on the rpoB and katG genes should be improved to cater for the genetic variations associated with the geographic specificity of the target genes and be able to detect most prevalent mutations in different areas.
Introduction
Tuberculosis remains the leading cause of death worldwide with the frequency of mutations in rifampicin and isoniazid resistance varying according to geographical location [1] . Tuberculosis (TB) is caused by Mycobacterium tuberculosis; a slow growing bacterium, which requires 4-8 weeks to isolate, identify and confirm drug susceptibility tests [2] [3] [4] . The emergence and spread of multi-drug resistant (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB) poses serious challenges in controlling tuberculosis.
Resistance to rifampicin is an indicator of possible multi-drug resistance as 90% of rifampicin (RIF) resistant strains are also isoniazid (INH) resistant [5] [6] [7] . MDR-TB is defined as TB that is resistant to the two first line anti-TB drugs rifampicin and isoniazid [8] . MDR-TB is a challenge to TB control due to its complex diagnostic and treatment obstacles. XDR-TB is currently defined as multi-drug resistant TB to at least the two most potent anti-TB drugs, rifampicin and isoniazid in addition to any one of the fluoroquinolones and at least one of the injectable second-line drugs; capreomycin, kanamycin and amikacin [9] . XDR-TB emerges through poor diagnosis and mismanagement of MDR-TB treatment. isolates have however been found to be resistant based on the culture methods but the genotyping machine has not been able to detect these resistant isolates [18] .
Although it has been observed that resistance conferring mutations are extensively studied and compiled into databases, not all mutations have been documented as observed from isolates that are phenotypically resistant but genotypically sensitive [18, 19] .
These isolates have been termed as discordant and are good candidates for this study and identification of novel resistance patterns in the rpoB and katG genes [19] . There is still a need to study the mutation patterns considering that much less than half of The study sought to detect mutations on rpoB, and katG genes of MTB from clinical samples from Zimbabwe using sequencing and subsequent analysis. Alternative diagnostic tests such as sequence based are necessary to bolster the amount of tuberculosis cases analysed for drug resistance [19] . This would require an established set of known mutations that are linked to resistance since not all mutations have been recorded as shown by isolates that lack mutations but still display resistance to antibiotics [16, 19, 23] . For example, the Hain's Genotype MTBDRplus kit has defined mutations and therefore, gene sequencing would be recommended to rule out any possible novel mutations [20] . Although certain mutations have been highly associated with drug resistance other mutations such as those recently discovered and still to be discovered could be utilized in sequence based testing to lower the discordance frequency and thus, increase the sensitivity [18] . With this in mind, significant geographical differences in the type of mutations as well as discordances have been found. This research was therefore also intended at generating more information that could be useful in enabling sequence based tests to be possibly targeted for each specific geographic region rather than using a single general test used worldwide [19, 20] . The objectives of this research was to determine the drug resistance profiles in M. tuberculosis isolates that are phenotypically resistant but not detected by the GeneXpert and MTBDRplus kit and also to detect mutations in the rpoB and katG genes which are not detected by the Hain Genotype MTBDRplus kit and GeneXpert diagnosis. 
Methods

Sample sources and processing:
The present study was conducted in the TB laboratory at BRTI and NUST. One hundred sputum specimens were included for investigation. Hundred isolates were collected from adult patients who were at least 16 years old.
These patients reported to several polyclinics in Harare from 
PCR and sequencing:
The PCR amplification of the rpoB and katG gene was performed using primers katG-F (5'-AGC TCG TAT GGC ACC GGA AC-3'), katG-R (5'-TTG ACC TCC CAC CCG ACT TG-3') and RPOB TR1 (5'-TACGGTCGGCGAGCTGATCC-3'), RPOB3R (5'-GTACGGCGTTTCGATGAACCCGAA-3') mentioned ( Figure 2 , Figure 3 ). The Figure 4 shows a diverse profile of the rpoB gene mutation that was yielded from this study. Figure   4 , Figure 5 ).
The Figure 6 shows that there was a diverse profile of the katG gene mutation that was yielded from this study. A higher number of isolates (57/92) 57% had mutation at codon 473 which is outside the determining region for the katG gene followed by 45 isolates at codon 471 and 472. Thirty-five isolates had mutations at codon 315 while other deletions have been observed at codon 491 on 9
isolates. Very close to the determining region for katG there were mutations at codon 303, 304 and 311 on 22 and 7 isolates giving a resistance pattern Table 2 , Figure 6 ). Hains Genotype MTBDRplus assay was reported as MDR after resistance have been detected in both isoniazid and rifampicin, Mono Rif/ Inh when the kit detected resistance to rifampicin only or isoniazid only. For GeneXpert the result was termed Rif sensitive when the isolate had no mutation in the RRDR region while it was termed resistant when the isolate had a mutation in the RRDR region. No sample result was recorded to an isolate that had very low sputum to be used for determing resistance since low levels of sputum or DNA can result in false positive results (Table 3) .
Discussion
Rifampicin resistance has been found to be associated with a In this study our finding was that 90% of RIF isolates were MDR-TB consistent with previous studies that say the majority of MTB In most of RIF resistant isolates had a WT band (found in drug susceptible strains) that was missing but corresponding MUT band (found in drug resistant strains) was present. This banding pattern is likely to be a result of mutations associated with drug resistance.
Another possible result pattern represents a silent mutation that does not result in amino acid change or may indicate the presence of less common mutations at the rpoB gene that cannot be detected by the current version 2 of the Genotype MTBDRplus kit [43] [44] [45] .
Another banding pattern that was frequent on 10 isolates was that of no wild type band and no corresponding mut bands which is a pattern that represents the presence of an unknown mutation causing resistance but not being detected by the kit. 
Conclusion
Our findings showed that the occurrence of specific rpoB mutations 
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